Track topics on Twitter Track topics that are important to you
Arena Pharmaceuticals and Sunesis Pharmaceuticals are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, earnings, profitability and institutional ownership. Arena Pharmaceuticals has a beta of 1.44, suggesting that its stock price is 44% more volatile than the S&P 500.
Original Article: Financial Contrast: Arena PharmaceuticalsNEXT ARTICLE